Literature DB >> 17010591

Immune dysregulation in asthma.

Dale T Umetsu1, Rosemarie H Dekruyff.   

Abstract

Allergic diseases and asthma are caused by dysregulated Th2-biased immune responses to environmental allergens in genetically predisposed individuals. Over the past several years there has been much progress in understanding the mechanisms by which Th2 responses are generated and the pathogenic role of natural killer T cells in asthma. In addition, there has been much progress in understanding the mechanisms of tolerance to allergens, the role of natural and adaptive allergen-specific regulatory T cells, and the strategies to prevent or to reverse allergic disease and asthma. Impaired expansion of regulatory T cells is hypothesized to lead to the development of allergy and asthma, and treatment to induce allergen-specific regulatory T cells could provide curative therapies for these problems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010591     DOI: 10.1016/j.coi.2006.09.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  21 in total

1.  Mina, an Il4 repressor, controls T helper type 2 bias.

Authors:  Mariko Okamoto; Melanie Van Stry; Linda Chung; Madoka Koyanagi; Xizhang Sun; Yoshie Suzuki; Osamu Ohara; Hiroshi Kitamura; Atsushi Hijikata; Masato Kubo; Mark Bix
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

Review 2.  Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences.

Authors:  L Li; V Boussiotis
Journal:  Chem Immunol Allergy       Date:  2008

Review 3.  CD8+ Tc2 cells: underappreciated contributors to severe asthma.

Authors:  Timothy S C Hinks; Ryan D Hoyle; Erwin W Gelfand
Journal:  Eur Respir Rev       Date:  2019-11-20

4.  Regulatory effects of IL-15 on allergen-induced airway obstruction.

Authors:  Sathisha Upparahalli Venkateshaiah; Xiang Zhu; Priya Rajavelu; Rituraj Niranjan; Murli Manohar; Alok K Verma; Joseph A Lasky; Anil Mishra
Journal:  J Allergy Clin Immunol       Date:  2017-06-09       Impact factor: 10.793

Review 5.  Chronic helminth infections protect against allergic diseases by active regulatory processes.

Authors:  Hermelijn H Smits; Bart Everts; Franca C Hartgers; Maria Yazdanbakhsh
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

6.  Parental stress increases the effect of traffic-related air pollution on childhood asthma incidence.

Authors:  Ketan Shankardass; Rob McConnell; Michael Jerrett; Joel Milam; Jean Richardson; Kiros Berhane
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

7.  Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model.

Authors:  Thomas Lowder; Kari Dugger; Jessy Deshane; Kim Estell; Lisa M Schwiebert
Journal:  Brain Behav Immun       Date:  2009-09-23       Impact factor: 7.217

8.  Severe vitamin E deficiency modulates airway allergic inflammatory responses in the murine asthma model.

Authors:  Yunsook Lim; Vihas T Vasu; Giuseppe Valacchi; Scott Leonard; Hnin Hnin Aung; Bettina C Schock; Nicholas J Kenyon; Chin-Shang Li; Maret G Traber; Carroll E Cross
Journal:  Free Radic Res       Date:  2008-04

9.  IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation.

Authors:  Clinton B Mathias; Eva-Jasmin Freyschmidt; Benjamin Caplan; Tatiana Jones; Dimitri Poddighe; Wei Xing; Krista L Harrison; Michael F Gurish; Hans C Oettgen
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population.

Authors:  James E Gern; Cynthia M Visness; Peter J Gergen; Robert A Wood; Gordon R Bloomberg; George T O'Connor; Meyer Kattan; Hugh A Sampson; Frank R Witter; Megan T Sandel; Wayne G Shreffler; Rosalind J Wright; Samuel J Arbes; William W Busse
Journal:  BMC Pulm Med       Date:  2009-05-08       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.